Genome & Company (KOSDAQ:314130)
South Korea · Delayed Price · Currency is KRW 2,735.00
-20.00 (-0.73%)
At close: Sep 17, 2025
-0.73% (1Y)
| Market Cap | 83.78B |
| Revenue (ttm) | 24.02B |
| Net Income (ttm) | -27.08B |
| Shares Out | 31.09M |
| EPS (ttm) | -875.42 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 86,399 |
| Average Volume | 95,781 |
| Open | 2,755.00 |
| Previous Close | 2,755.00 |
| Day's Range | 2,650.00 - 2,755.00 |
| 52-Week Range | 2,170.00 - 4,900.00 |
| Beta | 1.12 |
| RSI | 51.15 |
| Earnings Date | Nov 14, 2025 |